Market Closed -
London S.E.
11:35:01 2024-04-26 am EDT
|
5-day change
|
1st Jan Change
|
334.4
GBX
|
+0.87%
|
|
+2.64%
|
+3.96%
|
Fiscal Period: December |
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
30,229
|
29,703
|
30,538
|
-
|
-
|
Enterprise Value (EV)
1 |
40,097
|
38,217
|
38,384
|
37,643
|
37,089
|
P/E ratio
|
28.5
x
|
28.5
x
|
20.7
x
|
18.1
x
|
16.9
x
|
Yield
|
-
|
1.87%
|
1.88%
|
2.15%
|
2.39%
|
Capitalization / Revenue
|
2.78
x
|
2.63
x
|
2.67
x
|
2.56
x
|
2.45
x
|
EV / Revenue
|
3.69
x
|
3.38
x
|
3.35
x
|
3.15
x
|
2.97
x
|
EV / EBITDA
|
14.7
x
|
13.5
x
|
13.4
x
|
12.5
x
|
11.7
x
|
EV / FCF
|
22.8
x
|
20.5
x
|
26.2
x
|
22.1
x
|
20.4
x
|
FCF Yield
|
4.39%
|
4.88%
|
3.81%
|
4.53%
|
4.89%
|
Price to Book
|
1.85
x
|
1.79
x
|
1.79
x
|
1.69
x
|
1.59
x
|
Nbr of stocks (in thousands)
|
9,234,574
|
9,234,574
|
9,132,301
|
-
|
-
|
Reference price
2 |
3.274
|
3.216
|
3.344
|
3.344
|
3.344
|
Announcement Date
|
3/2/23
|
2/29/24
|
-
|
-
|
-
|
Fiscal Period: December |
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
10,858
|
11,302
|
11,447
|
11,931
|
12,473
|
EBITDA
1 |
2,730
|
2,831
|
2,866
|
3,019
|
3,167
|
EBIT
1 |
1,825
|
2,549
|
2,582
|
2,717
|
2,876
|
Operating Margin
|
16.81%
|
22.55%
|
22.56%
|
22.77%
|
23.05%
|
Earnings before Tax (EBT)
1 |
1,618
|
1,628
|
2,043
|
2,346
|
2,443
|
Net income
1 |
1,060
|
1,049
|
1,471
|
1,693
|
1,798
|
Net margin
|
9.76%
|
9.28%
|
12.85%
|
14.19%
|
14.42%
|
EPS
2 |
0.1150
|
0.1130
|
0.1616
|
0.1846
|
0.1975
|
Free Cash Flow
1 |
1,759
|
1,866
|
1,464
|
1,706
|
1,815
|
FCF margin
|
16.2%
|
16.51%
|
12.79%
|
14.3%
|
14.55%
|
FCF Conversion (EBITDA)
|
64.43%
|
65.91%
|
51.09%
|
56.53%
|
57.29%
|
FCF Conversion (Net income)
|
165.94%
|
177.88%
|
99.55%
|
100.78%
|
100.9%
|
Dividend per Share
2 |
-
|
0.0600
|
0.0630
|
0.0720
|
0.0800
|
Announcement Date
|
3/2/23
|
2/29/24
|
-
|
-
|
-
|
Fiscal Period: December |
2022 Q1
|
2022 Q2
|
2022 S1
|
2022 Q3
|
2022 Q4
|
2022 S2
|
2023 Q1
|
2023 Q2
|
2023 S1
|
2023 Q3
|
2023 Q4
|
2023 S2
|
2024 Q1
|
2024 Q2
|
2024 S1
|
2024 Q3
|
2024 Q4
|
2024 S2
|
2025 Q1
|
---|
Net sales
1 |
2,627
|
-
|
5,188
|
2,892
|
2,778
|
5,670
|
2,986
|
2,752
|
5,738
|
2,798
|
2,766
|
5,564
|
2,941
|
2,778
|
5,668
|
2,908
|
2,870
|
5,761
|
-
|
EBITDA
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
1,406
|
-
|
-
|
1,425
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
EBIT
1 |
-
|
-
|
-
|
569
|
356
|
-
|
627
|
644
|
1,271
|
689
|
589
|
1,278
|
590
|
476
|
-
|
638
|
439
|
-
|
-
|
Operating Margin
|
-
|
-
|
-
|
19.67%
|
12.81%
|
-
|
21%
|
23.4%
|
22.15%
|
24.62%
|
21.29%
|
22.97%
|
20.06%
|
17.13%
|
-
|
21.94%
|
15.29%
|
-
|
-
|
Earnings before Tax (EBT)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
172
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Net income
1 |
343
|
-
|
-
|
-
|
-
|
-
|
-
|
298
|
-
|
365
|
-3
|
-
|
368.2
|
322.6
|
-
|
461
|
359.6
|
-
|
-
|
Net margin
|
13.06%
|
-
|
-
|
-
|
-
|
-
|
-
|
10.83%
|
-
|
13.05%
|
-0.11%
|
-
|
12.52%
|
11.61%
|
-
|
15.85%
|
12.53%
|
-
|
-
|
EPS
2 |
-
|
0.0189
|
-
|
0.0400
|
-
|
-
|
-
|
0.0320
|
-
|
0.0390
|
-
|
-
|
0.0404
|
0.0354
|
-
|
0.0505
|
0.0394
|
-
|
-
|
Dividend per Share
2 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
0.0180
|
-
|
-
|
0.0420
|
-
|
-
|
0.0220
|
-
|
0.0643
|
0.0470
|
-
|
Announcement Date
|
6/1/22
|
9/29/22
|
9/29/22
|
11/10/22
|
3/2/23
|
3/2/23
|
5/3/23
|
8/2/23
|
8/2/23
|
11/2/23
|
2/29/24
|
2/29/24
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Fiscal Period: December |
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
1 |
9,868
|
8,514
|
7,846
|
7,105
|
6,551
|
Net Cash position
1 |
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
3.615
x
|
3.007
x
|
2.738
x
|
2.354
x
|
2.068
x
|
Free Cash Flow
1 |
1,759
|
1,866
|
1,464
|
1,706
|
1,815
|
ROE (net income / shareholders' equity)
|
4.97%
|
6.37%
|
9.76%
|
10%
|
10.3%
|
ROA (Net income/ Total Assets)
|
3.06%
|
3.05%
|
4.48%
|
4.77%
|
5.07%
|
Assets
1 |
34,633
|
34,435
|
32,797
|
35,477
|
35,484
|
Book Value Per Share
2 |
1.770
|
1.790
|
1.860
|
1.980
|
2.100
|
Cash Flow per Share
2 |
0.2200
|
0.2300
|
0.1600
|
0.2100
|
0.2300
|
Capex
1 |
304
|
234
|
338
|
342
|
368
|
Capex / Sales
|
2.8%
|
2.07%
|
2.95%
|
2.87%
|
2.95%
|
Announcement Date
|
3/2/23
|
2/29/24
|
-
|
-
|
-
|
Last Close Price
3.344
GBP Average target price
3.594
GBP Spread / Average Target +7.47% Consensus |
1st Jan change
|
Capi.
|
---|
| +3.96% | 38.04B | | +25.83% | 661B | | +27.00% | 566B | | -6.76% | 352B | | +20.34% | 332B | | +3.00% | 283B | | +13.09% | 231B | | +5.46% | 200B | | -9.61% | 195B | | -6.26% | 145B |
Other Pharmaceuticals
|